Skip to content

Gait Training for Individuals With Paraplegia Using the H-MEX Exoskeleton

Effects of Gait Training for Individuals With Paraplegia Using H-MEX Exoskeleton: A Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04055610
Enrollment
10
Registered
2019-08-14
Start date
2019-08-08
Completion date
2020-12-31
Last updated
2019-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paraplegia, Spinal Cord Injuries

Keywords

H-MEX powered exoskeleton, Exoskeleton

Brief summary

This study evaluates the feasibility and effects of H-MEX powered exoskeleton in individuals with paraplegia as a result of spinal cord injury.

Detailed description

Participants with paraplegia will attend gait training using H-MEX powered exoskeleton 3 times a week for 10 weeks. The aim of this study is to assess the impact of gait training using H-MEX powered exoskeleton on walking ability, gait analysis, medical examination, body composition, functional evaluation, laboratory findings, quality of life, and subjective experience in individuals with paraplegia. Participants will be evaluated before, during, and after training.

Interventions

DEVICEGait training using H-MEX exoskeleton

Participants will train 3 times a week for 10 weeks using H-MEX powered exoskeleton.

Sponsors

Hyundai Motor Company
CollaboratorINDUSTRY
Hanyang University Seoul Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Neurologically stable paraplegia due to traumatic or non-traumatic spinal cord injury at least 2 months since injury * Age more than 18 years * Body weight less than 110kg, height between 160-180cm * Sufficient postural stability to perform level transfer * Sufficient upper extremity strength to use a walker or crutch

Exclusion criteria

* Spinal instability * Severe joint contracture in lower extremity * Unhealed fracture in the major weight bearing bone in the lower extremity * Skin compromise in areas of contact with the device * Unresolved deep vein thrombosis * Uncontrolled hypertension or hypotension * Severe osteoporosis or osteoporotic fracture unable to gait training * Lower extremity spasticity exceeding 3 out of 4 (Modified Ashworth Scale) in any joint * Upper extremity functional limitation due to weakness or contracture * Psychological or cognitive problem that may limit the participants to understand instructions by investigator * Any other issue that may interfere with the trial

Design outcomes

Primary

MeasureTime frameDescription
Dropout rate0-14 weeksPercentage of participants who drop out before the end of the training period.
Number of adverse events0-14 weeksTypes and number of the adverse events both serious and non-serious events during training sessions.

Secondary

MeasureTime frameDescription
Changes in Berg balance test with H-mex exoskeletonInitial evaluation, mid-evaluation (after 5 weeks of training), and Final evaluation (after 10 weeks of training)Balance will be evaluated by using Berg balance test which is 14-item test designed to assess balance (score range: 0-56, higher values represent a better outcome).
Changes in body compositionInitial evaluation, mid-evaluation (after 5 weeks of training), and Final evaluation (after 10 weeks of training)Body composition will be assessed by using bioelectric impedence analysis.
Changes in oxygen uptake during gait training with H-mex exoskeletonInitial evaluation, mid-evaluation (after 5 weeks of training), and Final evaluation (after 10 weeks of training)Average and peak oxygen uptake will be measured with participants during gait training.
Changes in heart rate during gait training with H-mex exoskeletonInitial evaluation, mid-evaluation (after 5 weeks of training), and Final evaluation (after 10 weeks of training)Average and peak heart rate will be measured with participants during gait training.
Changes in 6 minute walking test with H-mex exoskeletonInitial evaluation, mid-evaluation (after 5 weeks of training), and Final evaluation (after 10 weeks of training)Distance walked over a span of 6 minutes will be examined.
Changes in colonic transit timeInitial evaluation and Final evaluation (after 10 weeks of training)Colonic mobility will be assessed by colonic transit time.
Changes in quality of life: Short-Form 36-Item Health Survey version 2Initial evaluation and Final evaluation (after 10 weeks of training)Quality of life will be assessed by Short-Form 36-Item Health Survey version 2 (total score range: 0-100, higher values represent a better outcome).
Changes in fear for fallInitial evaluation and Final evaluation (after 10 weeks of training)Fear for fall will be assessed by fall efficacy scale which is 16-item test (score range: 16-64, higher values represent a worse outcome).
Changes in bone mineral densityInitial evaluation and Final evaluation (after 10 weeks of training)Bone mineral density will be measured at hip and spine by dual energy X-ray absorptiometry.
Changes in timed up and go test with H-mex exoskeletonInitial evaluation, mid-evaluation (after 5 weeks of training), and Final evaluation (after 10 weeks of training)Time that a participants takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down will be measured.

Countries

South Korea

Contacts

Primary ContactMi Jung Kim, MD PhD
kimmjreh@hanyang.ac.kr82-10-2067-9353

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026